Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney

Drug Metabolism and Disposition

Volumn 33, Issue 4, 2005, Pages 495-499

  Ishiguro, Naoki ^a,b   Saito, Asami ^b   Yokoyama, Kazutoshi ^b   Morikawa, Makoto ^b   Igarashi, Takashi ^b   Tamai, Ikumi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b Boehringer Ingelheim Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CORTICOSTERONE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 2; PRAMIPEXOLE; PROCAINAMIDE; UNCLASSIFIED DRUG; AMANTADINE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE 2 RECEPTOR; ISOPROTEIN; ORGANIC CATION TRANSPORTER 1; PRAMIPEXOL; SLC22A2 PROTEIN, RAT; THIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TRANSPORT; IC 50; KIDNEY PROXIMAL TUBULE; KIDNEY SLICE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EPITHELIUM; KIDNEY TUBULE EXCRETION; MALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; XENOPUS; ANIMAL; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT; XENOPUS LAEVIS;

AMANTADINE; ANIMALS; BENZOTHIAZOLES; CORTICOSTERONE; FEMALE; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; OOCYTES; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; PROCAINAMIDE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; THIAZOLES; XENOPUS LAEVIS;

EID: 15344346237     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002519     Document Type: Article

References (35)

1. Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, et al. (2001) Interaction of cations, anions and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. Am J Physiol 281:F454-F468.
2. Chen R, Jonker JW, and Nelson JA (2002) Renal organic cation and nucleoside transport. Biochem Pharmacol 64:185-190.
3. Domino EF, Ni L, Zhang H, Kohno Y, and Sasa M (1997) Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys. Eur J Pharmacol 325:137-144.
4. Goralski KB, Lou G, Prowse MT, Gorboulev V, Volk C, Koepsell H, and Sitar DS (2002) The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules. J Pharmacol Exp Ther 303:959-968.
5. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, and Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871-881.
6. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, and Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature (Lond) 372:549-552.
7. Hayden FG, Minocha A, Spyker DA, and Hoffman HE (1985) Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrob Agents Chemother 28:216-221.
8. Hubble JP (2000) Pre-clinical studies of pramipexole: clinical relevance. Eur J Neurol 7:15-20.
9. Jonker JW, Wagenaar E, Mol CA, Buitelaar M, Koepsell H, Smit JW, and Schinkel AH (2001) Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Mol Cell Biol 21:5471-5477.
10. Jonker JW, Wagenaar E, Van Eijl S, and Schinkel AH (2003) Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23:7902-7908.
11. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, and Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979.
12. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, and Endou H (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675-13680.
13. Martel F, Ribeiro L, Calhau C, and Azevedo I (1999) Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone. Naunyn Schmiedeberg's Arch Pharmacol 359:303-309.
14. Mierau J and Schingnitz G (1992) Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist. Eur J Pharmacol 215:161-170.
15. Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, and Huff RM (1995) Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur J Pharmacol 290:29-36.
16. Okuda M, Saito H, Urakami Y, Takano M, and Inui K (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun 224:500-507.
17. Pietig G, Mehrens T, Hirsch JR, Cetinkaya I, Piechota H, and Schlatter E (2001) Properties and regulation of organic cation transport in freshly isolated human proximal tubules. J Biol Chem 276:33741-33746.
18. Schweifer N and Barlow DP (1996) The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mamm Genome 7:735-740.
19. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, and Endou H (1998) Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429:179-182.
20. Slitt AL, Cherrington NJ, Hartley DP, Leazer TM, and Klaassen CD (2002) Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30:212-219.
21. Tamai I, China K, Sai Y, Kobayashi D, Nezu J, Kawahara E, and Tsuji A (2001) Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512:273-284.
22. Tamai I, Nakanishi T, Kobayashi D, China K, Kosugi Y, Nezu J, Sai Y, and Tsuji A (2004) Involvement of OCTN1(SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1:57-66.
23. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
24. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, and Tsuji A (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
25. Thomas MC, Tikellis C, Burns WC, Thallas V, Forbes JM, Cao Z, Osicka TM, Russo LM, Jerums G, Ghabrial H, et al. (2003) Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney Int 63:2152-2161.
26. Urakami Y, Nakamura N, Takahashi K, Okuda M, Saito H, Hashimoto Y, and Inui K (1999) Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Lett 461:339-342.
27. Urakami Y, Okuda M, Masuda S, Saito H, and Inui KI (1998) Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther 287:800-805.
28. Uwai Y, Okuda M, Takami K, Hashimoto Y, and Inui K (1998) Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 438:321-324.
29. van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, and Meijer DK (2003) Drug uptake systems in liver and kidney. Curr Drug Metab 4:185-211.
30. Wright CE, Sisson TL, Ichhpurani AK, and Peters GR (1997) Steady-state pharmacokinetic properties of pramipexole in healthy volunteers. J Clin Pharmacol 37:520-525.
31. Wu MJ, Ing TS, Soung LS, Daugirdas JT, Hano JE, and Gandhi VC (1982) Amantadine hydrochloride pharmacokinetics in patients with impaired renal function. Clin Nephrol 17:19-23.
32. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, and Ganapathy V (1998a) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786.
33. Wu X, Prasad PD, Leibach FH, and Ganapathy V (1998b) cDNA sequence, transport function and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.
34. Yamamura N, Tatami S, and Igarashi T (2004) Population pharmacokinetic analysis based on the data of Japanese patients (Abstract). Jpn J Clin Pharmacol Ther 35:232.
35. Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T (1981) A pharmacokinetic analysis program (MULT1) for microcomputer. J Pharmacobio-Dyn 4:879-885.